SCHEMBL24663196

SCHEMBL24663196

CC(C)CC1CCC(C)N1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15533188 0.86 CYP2C9 (0.50) CYP2C9TSHRCYP2C19TDP1
SCHEMBL9820867 0.86 CYP2C9 (0.33) CYP2C9TSHRCYP2C19TDP1
SCHEMBL8665389 0.85 PLG (0.31)
SCHEMBL6380793 0.75 TSHR (0.33) CYP2C9TSHRCYP2C19TDP1
SCHEMBL22598596 0.74
SCHEMBL21942645 0.73
SCHEMBL4602653 0.72
SCHEMBL11607063 0.72
SCHEMBL24350290 0.72
SCHEMBL15828874 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023172737-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-09-14 WO disclosed
WO-2022266015-A1 FUSED HETEROARYL COMPOUNDS USEFUL AS ANTICANCER AGENTS KUMQUAT BIOSCIENCES INC. (US) 2022-12-22 WO disclosed
WO-2022214102-A1 HETEROCYCLIC COMPOUND ACTING AS KRAS G12D INHIBITOR 杭州英创医药科技有限公司 2022-10-13 WO disclosed